Correlation Between GLOBUS MEDICAL and BECLE SAB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GLOBUS MEDICAL and BECLE SAB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GLOBUS MEDICAL and BECLE SAB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GLOBUS MEDICAL A and BECLE SAB DE, you can compare the effects of market volatilities on GLOBUS MEDICAL and BECLE SAB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GLOBUS MEDICAL with a short position of BECLE SAB. Check out your portfolio center. Please also check ongoing floating volatility patterns of GLOBUS MEDICAL and BECLE SAB.

Diversification Opportunities for GLOBUS MEDICAL and BECLE SAB

-0.89
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GLOBUS and BECLE is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding GLOBUS MEDICAL A and BECLE SAB DE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BECLE SAB DE and GLOBUS MEDICAL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GLOBUS MEDICAL A are associated (or correlated) with BECLE SAB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BECLE SAB DE has no effect on the direction of GLOBUS MEDICAL i.e., GLOBUS MEDICAL and BECLE SAB go up and down completely randomly.

Pair Corralation between GLOBUS MEDICAL and BECLE SAB

Assuming the 90 days trading horizon GLOBUS MEDICAL A is expected to generate 0.58 times more return on investment than BECLE SAB. However, GLOBUS MEDICAL A is 1.72 times less risky than BECLE SAB. It trades about 0.03 of its potential returns per unit of risk. BECLE SAB DE is currently generating about 0.01 per unit of risk. If you would invest  6,750  in GLOBUS MEDICAL A on September 28, 2024 and sell it today you would earn a total of  1,100  from holding GLOBUS MEDICAL A or generate 16.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GLOBUS MEDICAL A  vs.  BECLE SAB DE

 Performance 
       Timeline  
GLOBUS MEDICAL A 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in GLOBUS MEDICAL A are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, GLOBUS MEDICAL exhibited solid returns over the last few months and may actually be approaching a breakup point.
BECLE SAB DE 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BECLE SAB DE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

GLOBUS MEDICAL and BECLE SAB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GLOBUS MEDICAL and BECLE SAB

The main advantage of trading using opposite GLOBUS MEDICAL and BECLE SAB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GLOBUS MEDICAL position performs unexpectedly, BECLE SAB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BECLE SAB will offset losses from the drop in BECLE SAB's long position.
The idea behind GLOBUS MEDICAL A and BECLE SAB DE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope